Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Epidemics. 2017 Feb 21;19:74–82. doi: 10.1016/j.epidem.2017.02.008

Table 1.

Coverage levels considered for both the monovalent and the bivalent vaccines in our simulations.

Coverage scenario Monovalent vaccine coverage Bivalent vaccine coverage
Uniform coverage 100% children/100% adults 100% children/100% adults
50% increase 60% children/45% adults 60% children/45% adults
25% increase 50% children/37.5% adults 50% children/37.5% adults
10% increase 44% children/33% adults 44% children/33% adults
Baseline level 40% children/30% adults 40% children/30% adults
10% reduction 36% children/27% adults 36% children/27% adults
25% reduction 30% children/22.5% adults 30% children/22.5% adults
40% reduction 24% children/18% adults 24% children/18% adults